Skip to Content

Baxter International Inc

BAX: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$66.00JxqszyBhmgwgfcp

Baxter Earnings: Better Than Expected but Down on Previous Supply Chain Pressures

Narrow-moat Baxter mildly exceeded expectations in the first quarter, and management raised its outlook for 2023. We increased our expectations for 2023 slightly, but that did not have a material impact on our $67 fair value estimate. Shares remain undervalued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of BAX so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center